Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Update on typical and atypical antipsychotic drugs.

Meltzer HY.

Annu Rev Med. 2013;64:393-406. doi: 10.1146/annurev-med-050911-161504. Epub 2012 Sep 27. Review.

PMID:
23020880
[PubMed - indexed for MEDLINE]
2.

Extrapyramidal side effects of antipsychotic treatment: scope of problem and impact on outcome.

Tandon R, Jibson MD.

Ann Clin Psychiatry. 2002 Jun;14(2):123-9. Review.

PMID:
12238737
[PubMed - indexed for MEDLINE]
3.

What's atypical about atypical antipsychotic drugs?

Meltzer HY.

Curr Opin Pharmacol. 2004 Feb;4(1):53-7.

PMID:
15018839
[PubMed - indexed for MEDLINE]
4.

The role of serotonin receptors in the action of atypical antipsychotic drugs.

Meltzer HY, Massey BW.

Curr Opin Pharmacol. 2011 Feb;11(1):59-67. doi: 10.1016/j.coph.2011.02.007. Epub 2011 Mar 21. Review.

PMID:
21420906
[PubMed - indexed for MEDLINE]
5.

Regional differences in the action of antipsychotic drugs: implications for cognitive effects in schizophrenic patients.

Beninger RJ, Baker TW, Florczynski MM, Banasikowski TJ.

Neurotox Res. 2010 Nov;18(3-4):229-43. doi: 10.1007/s12640-010-9178-y. Epub 2010 Apr 8. Review.

PMID:
20376711
[PubMed - indexed for MEDLINE]
6.

Serotonergic mechanisms as targets for existing and novel antipsychotics.

Meltzer HY.

Handb Exp Pharmacol. 2012;(212):87-124. doi: 10.1007/978-3-642-25761-2_4. Review.

PMID:
23129329
[PubMed - indexed for MEDLINE]
7.

Atypical antipsychotics: mechanism of action.

Seeman P.

Can J Psychiatry. 2002 Feb;47(1):27-38. Review.

PMID:
11873706
[PubMed - indexed for MEDLINE]
8.

Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum.

Bubser M, Deutch AY.

Eur J Neurosci. 2002 Feb;15(4):713-20.

PMID:
11886451
[PubMed - indexed for MEDLINE]
9.

Serotonin receptors: their key role in drugs to treat schizophrenia.

Meltzer HY, Li Z, Kaneda Y, Ichikawa J.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1159-72. Review.

PMID:
14642974
[PubMed - indexed for MEDLINE]
10.

Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia.

Meltzer HY, Massey BW, Horiguchi M.

Curr Pharm Biotechnol. 2012 Jun;13(8):1572-86. Review.

PMID:
22283753
[PubMed - indexed for MEDLINE]
11.

The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia.

Sumiyoshi T, Jayathilake K, Meltzer HY.

Schizophr Res. 2003 Jan 1;59(1):7-16.

PMID:
12413636
[PubMed - indexed for MEDLINE]
12.

Atypical antipsychotic agents: a critical review.

Worrel JA, Marken PA, Beckman SE, Ruehter VL.

Am J Health Syst Pharm. 2000 Feb 1;57(3):238-55. Review.

PMID:
10674777
[PubMed - indexed for MEDLINE]
13.

The new antipsychotics. How much better are they?

Keks N, Mazumdar P, Steele K.

Aust Fam Physician. 2000 May;29(5):445-50. Review.

PMID:
10835782
[PubMed - indexed for MEDLINE]
14.

Antipsychotic drugs for first-episode schizophrenia: a comparative review.

Salimi K, Jarskog LF, Lieberman JA.

CNS Drugs. 2009 Oct;23(10):837-55. doi: 10.2165/11314280-000000000-00000. Review.

PMID:
19739694
[PubMed - indexed for MEDLINE]
15.

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

Woodward ND, Purdon SE, Meltzer HY, Zald DH.

Int J Neuropsychopharmacol. 2005 Sep;8(3):457-72. Epub 2005 Mar 23. Review.

PMID:
15784157
[PubMed - indexed for MEDLINE]
16.

Olanzapine for schizophrenia.

Duggan L, Fenton M, Rathbone J, Dardennes R, El-Dosoky A, Indran S.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD001359. Review.

PMID:
15846619
[PubMed - indexed for MEDLINE]
17.

Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.

Ogino S, Miyamoto S, Miyake N, Yamaguchi N.

Psychiatry Clin Neurosci. 2014 Jan;68(1):37-49. doi: 10.1111/pcn.12088. Epub 2013 Sep 19. Review.

PMID:
24102938
[PubMed - indexed for MEDLINE]
18.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

PMID:
16707074
[PubMed - indexed for MEDLINE]
Free Article
19.
20.

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

Kane JM, Leucht S, Carpenter D, Docherty JP; Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.

J Clin Psychiatry. 2003;64 Suppl 12:5-19.

PMID:
14640142
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk